![Chris Chapman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chris Chapman
Corporate Officer/Principal bei Dermavant Sciences Ltd.
Aktive Positionen von Chris Chapman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Dermavant Sciences Ltd.
![]() Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 22.01.2020 | - |
Karriereverlauf von Chris Chapman
Ausbildung von Chris Chapman
Towson University | Undergraduate Degree |
Statistik
International
Vereinigtes Königreich | 2 |
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Dermavant Sciences Ltd.
![]() Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Chris Chapman
- Erfahrung